<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01199848</url>
  </required_header>
  <id_info>
    <org_study_id>STRB 2010-033</org_study_id>
    <nct_id>NCT01199848</nct_id>
  </id_info>
  <brief_title>A Study of Strawberries and Disease Risk</brief_title>
  <acronym>STRB</acronym>
  <official_title>Effect of Strawberry on Oxidative Stress- and Inflammatory-mediated Insulin Resistance (IR) in Humans: Combating a Major Risk Factor for Diabetes and Cardiovascular Disease Through Diet</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinical Nutrition Research Center, Illinois Institute of Technology</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>California Strawberry Commission</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinical Nutrition Research Center, Illinois Institute of Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test whether compounds found in strawberries (polyphenolics&#xD;
      which are typically found in berry products, tea, coffee, red wine, and chocolate) will help&#xD;
      reduce insulin resistance and inflammation, known factors in your blood associated with&#xD;
      disease risk, when eaten with a standard high fat/carbohydrate meal.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main study is a single-center, randomized, cross-over, 4-arm, dose-response, single-&#xD;
      blinded, 6-hour postprandial study to evaluate the ability of strawberry powder to block&#xD;
      meal-induced oxidative stress and inflammation and concomitantly improve postprandial insulin&#xD;
      sensitivity and glucose handling.&#xD;
&#xD;
      A planned sample size of 45 will be recruited into the study. Thirty subjects for the main&#xD;
      study and 15 subjects for the complement study. Subjects can participate in both studies and&#xD;
      if subjects participate in both studies, there will be a time gap between the main study and&#xD;
      the complement study due to the volume of blood permitted to collect within 56 days.&#xD;
&#xD;
      The complement study will be a 2-arm placebo controlled study following the exact same&#xD;
      protocol as the main study, but using only one strawberry dose (Dose 3 as in the main study)&#xD;
      and comparing the effects relative to a placebo that does not control for fiber.&#xD;
&#xD;
      The main study will take 5- 6 weeks per subject to complete and the complement study will&#xD;
      take 1-2 weeks per subject to complete, depending on subject's schedule.&#xD;
&#xD;
      The procedures conducted at the screening visit include blood sampling by finger prick for a&#xD;
      fasting blood sugar test and anthropometric measurements (height, weight, and waist&#xD;
      circumference), vital sign measurements (blood pressure and heart rate) and completion of a&#xD;
      series of questionnaires relating to volunteers' general health and eating habits. Volunteers&#xD;
      may be asked to complete an oral glucose/sugar tolerance test (OGTT) at screening. Volunteers&#xD;
      will be exempt from the OGTT procedure if other qualifying conditions are present. Briefly,&#xD;
      subjects undergoing OGTT will be asked to drink a glucose drink (similar in taste to&#xD;
      kool-aid) in the morning after a 10 hour fast. Blood glucose finger pricks will then be done&#xD;
      at 1 hour and 2 hours for determination of glucose tolerance. If the OGTT is necessary,&#xD;
      additional compensation will be provided.&#xD;
&#xD;
      If qualified, subjects will undergo a 7-day pre-study period during which they will be asked&#xD;
      to record their usual diet intake for 3 days, including 2 weekdays and 1 weekend day, EITHER&#xD;
      followed by randomization into 1 of 4 treatment beverage sequences for the main study:&#xD;
      Placebo (Pbo), Strawberry Dose 1, Strawberry Dose 2 and Strawberry Dose 3, OR followed by&#xD;
      randomization into 1 of 2 treatment (Placebo without fiber and Strawberry Dose 3) beverage&#xD;
      sequences for the complement study.&#xD;
&#xD;
      We expect it to be very difficult to eliminate or severely restrict polyphenolic diet during&#xD;
      the entire study period, therefore subjects will be asked to limit only berry product intake&#xD;
      during the study period. However, subjects will be asked to limit all polyphenolic foods in&#xD;
      their diet for 3 days prior to each study visit.&#xD;
&#xD;
      All subjects will consume the standard high fat/ carbohydrate meal (known to induce&#xD;
      oxidative- and inflammatory- stress) accompanied by 1 of 4 test beverages (whole milk shake&#xD;
      with or without strawberry powder) on four separate occasions for the main study OR 1 of 2&#xD;
      test beverages on two separate occasions for the complement study, so that each subject will&#xD;
      serve as their own control.&#xD;
&#xD;
      Subjects will arrive at the study visits fasted for at least 10 hours, well hydrated and&#xD;
      rested. Each study visit will require blood draws throughout the visit. After pre-study&#xD;
      procedures (height, weight, waist circumference, blood pressure, blood glucose finger prick)&#xD;
      and while fasting, a registered nurse (RN) will place a catheter (flexible tubing) in&#xD;
      subjects' arm for the purpose of drawing blood. This catheter will remain only throughout the&#xD;
      study day. Approximately 1 tablespoon of blood will be taken at this time. The test meal and&#xD;
      strawberry shake will be served and thereafter subjects will have blood draws (1 T each time)&#xD;
      at designated time points for the next 6 hours. Each visit will last approximately 7 hours&#xD;
      and subjects will be required to remain at the Clinical Nutrition Research Center on the IIT&#xD;
      Campus for the duration of the visit. Blood samples will be collected at designated time&#xD;
      points during the postprandial period for analysis of metabolic (insulin and glucose&#xD;
      homeostasis), oxidative and inflammatory endpoint markers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 15, 2010</start_date>
  <completion_date type="Actual">October 15, 2015</completion_date>
  <primary_completion_date type="Actual">October 15, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postprandial Insulin Levels for 6 Hours</measure>
    <time_frame>6 hour postprandial study over 4 periods</time_frame>
    <description>Strawberry dose-response effect on Postprandial glycemic control in insulin resistant individuals.plasma insulin concentration is measured over 6 hours by Randox clinical analyzer, analyzed with SAS mixed model.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Strawberry Dose-response Effect on Postprandial Oxidative Stress (Ox-LDL) in Insulin-resistant Men and Women in an Acute Postprandial Paradigm</measure>
    <time_frame>6 hours postprandial study over 4 periods(treatments)</time_frame>
    <description>Postprandial plasma Ox-LDL concentration was measured by ELISA method. Normalizing responses to subjects own baseline (Time 0) was analyzed by SAS mixed model.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">29</enrollment>
  <condition>Nutritional and Metabolic Diseases</condition>
  <condition>Inflammation</condition>
  <condition>Physiological Responses</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Pbo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10G STRB powder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dose 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>20G STRB powder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dose 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>40G STRB powder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dose 3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PlacebonoFiber</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo without fiber</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>whole milk shake without strawberry powder served with the high fat/carbohydrate test meal</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Pbo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>10G</intervention_name>
    <description>whole milk shake with 10g strawberry powder served with the high fat/carbohydrate test meal</description>
    <arm_group_label>10G STRB powder</arm_group_label>
    <other_name>Dose 1</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>20G</intervention_name>
    <description>whole milk shake with 20 strawberry powder served with the high fat/carbohydrate test meal</description>
    <arm_group_label>20G STRB powder</arm_group_label>
    <other_name>Dose 2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>40G</intervention_name>
    <description>whole milk shake with 40g strawberry powder served with the high fat/carbohydrate test meal</description>
    <arm_group_label>40G STRB powder</arm_group_label>
    <other_name>Dose 3</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebonofiber</intervention_name>
    <description>Placebo without Fiber</description>
    <arm_group_label>PlacebonoFiber</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Eligible volunteers must meet ONE or MORE of the criteria (numbers 1-4) associated with&#xD;
        insulin resistance along with all of the other criteria listed (numbers 5-9):&#xD;
&#xD;
          1. Blood glucose concentration between140-199 mg/dL at 2hr from OGTT.&#xD;
&#xD;
          2. Elevated fasting glucose (≥110 mg/dL and &lt;126 mg/dL)&#xD;
&#xD;
          3. Elevated fasting insulin (&gt;75th percentile cutoff of 13.13 μU/mL)&#xD;
&#xD;
          4. Insulin resistance defined by the homeostasis model assessment method of insulin&#xD;
             resistance (HOMA-IR) (glucose [in millimoles per liter] × insulin [in microunits per&#xD;
             milliliter]/22.5) values of at least 2.5.&#xD;
&#xD;
          5. Waist circumference &gt;102 cm (men) and &gt; 88 cm (women) for screening visit invitation&#xD;
             because many epidemiology studies have been shown that waist circumferences may be&#xD;
             related to insulin resistance.&#xD;
&#xD;
          6. Nonsmokers&#xD;
&#xD;
          7. Not taking any medications that would interfere with outcomes of the study, i.e. lipid&#xD;
             lowering medications, anti-inflammatory drugs, or dietary supplements&#xD;
&#xD;
          8. 18 years of age and older&#xD;
&#xD;
          9. No clinical evidence of cardiovascular, metabolic, respiratory, renal,&#xD;
             gastrointestinal or hepatic disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant and/or lactating&#xD;
&#xD;
          -  Allergy or intolerance to strawberries and dairy products.&#xD;
&#xD;
          -  Current regular consumption of strawberries is &gt; 2 servings per day.&#xD;
&#xD;
          -  Fasting blood glucose ≥ 126 mg/dL. Subjects identified with elevated fasting blood&#xD;
             glucose levels will be advised to contact their primary care physician for appropriate&#xD;
             follow-up care.&#xD;
&#xD;
          -  Taking over the counter antioxidant supplements or other supplements that may&#xD;
             interfere with the study procedures or endpoints.&#xD;
&#xD;
          -  Subjects with unusual dietary habits (e.g. pica).&#xD;
&#xD;
          -  Actively losing weight or trying to lose weight (unstable body weight fluctuations of&#xD;
             &gt; 5 kg in a 60 day period).&#xD;
&#xD;
          -  Excessive exercisers or trained athletes.&#xD;
&#xD;
          -  Subjects with documented atherosclerotic disease, inflammatory disease, diabetes&#xD;
             mellitus, or other systemic diseases.&#xD;
&#xD;
          -  Addicted to drugs and/or alcohol.&#xD;
&#xD;
          -  Medically documented psychiatric or neurological disturbances.&#xD;
&#xD;
          -  Smoker (past smoker may be allowed if cessation is &gt; 2 years)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Indika Edirisinghe, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Food Safety and Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Britt Burton-Freeman, PhD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Food Safety and Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Nutrition Research Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60616</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Burton-Freeman B, Linares A, Hyson D, Kappagoda T. Strawberry modulates LDL oxidation and postprandial lipemia in response to high-fat meal in overweight hyperlipidemic men and women. J Am Coll Nutr. 2010 Feb;29(1):46-54.</citation>
    <PMID>20595645</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>September 9, 2010</study_first_submitted>
  <study_first_submitted_qc>September 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2010</study_first_posted>
  <results_first_submitted>April 24, 2018</results_first_submitted>
  <results_first_submitted_qc>January 25, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">February 12, 2021</results_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>nutrition</keyword>
  <keyword>polyphenolic</keyword>
  <keyword>strawberry</keyword>
  <keyword>insulin resistance</keyword>
  <keyword>metabolic syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The study was conducted in Chicago, IL, USA from September 2010 to January 2013.</recruitment_details>
      <pre_assignment_details>7-day pre-study period: Following the screening visit, qualified subjects were asked to record their usual diet intake for 3 days, including 2 weekdays and 1 weekend day in order to know their usual intake and to coach them on what foods in their diet are rich in polyphenolics, especially 3 days prior to their each study visit.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>All Study Participants</title>
          <description>All participants received all 4 interventions (Placebo, STRB 10g, STRB 20g, and STRB 40g) in a randomized sequence&#xD;
Placebo: whole milk shake without strawberry powder served with the high fat/carbohydrate test meal Dose 1-10G: whole milk shake with 10g strawberry powder served with the high fat/carbohydrate test meal Dose 2- 20G: whole milk shake with 20 strawberry powder served with the high fat/carbohydrate test meal Dose 3-40G: whole milk shake with 40g strawberry powder served with the high fat/carbohydrate test meal</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Placebo Arm</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>10g STR Arm</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>20G STRB Arm</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>40G STRB Arm</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Subject characteristics were analyzed using descriptive statistics and tabulated.</population>
      <group_list>
        <group group_id="B1">
          <title>All Participants</title>
          <description>All participants received all 4 interventions (Placebo, STRB 10g, STRB 20g, and STRB 40g) in a randomized sequence Placebo: whole milk shake without strawberry powder served with the high fat/carbohydrate test meal Dose 1-10G: whole milk shake with 10g strawberry powder served with the high fat/carbohydrate test meal Dose 2- 20G: whole milk shake with 20 strawberry powder served with the high fat/carbohydrate test meal Dose 3-40G: whole milk shake with 40g strawberry powder served with the high fat/carbohydrate test meal</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39.8" spread="13.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Postprandial Insulin Levels for 6 Hours</title>
        <description>Strawberry dose-response effect on Postprandial glycemic control in insulin resistant individuals.plasma insulin concentration is measured over 6 hours by Randox clinical analyzer, analyzed with SAS mixed model.</description>
        <time_frame>6 hour postprandial study over 4 periods</time_frame>
        <population>study completer who finished all 4 treatments.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Pbo&#xD;
Placebo: whole milk shake without strawberry powder served with the high fat/carbohydrate test meal</description>
          </group>
          <group group_id="O2">
            <title>10G STRB Powder</title>
            <description>Dose 1&#xD;
10G: whole milk shake with 10g strawberry powder served with the high fat/carbohydrate test meal</description>
          </group>
          <group group_id="O3">
            <title>20G STRB Powder</title>
            <description>Dose 2&#xD;
20G: whole milk shake with 20 strawberry powder served with the high fat/carbohydrate test meal</description>
          </group>
          <group group_id="O4">
            <title>40G STRB Powder</title>
            <description>Dose 3&#xD;
40G: whole milk shake with 40g strawberry powder served with the high fat/carbohydrate test meal</description>
          </group>
        </group_list>
        <measure>
          <title>Postprandial Insulin Levels for 6 Hours</title>
          <description>Strawberry dose-response effect on Postprandial glycemic control in insulin resistant individuals.plasma insulin concentration is measured over 6 hours by Randox clinical analyzer, analyzed with SAS mixed model.</description>
          <population>study completer who finished all 4 treatments.</population>
          <units>microIU/mL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="21"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.9" spread="5.6"/>
                    <measurement group_id="O2" value="64.3" spread="5.6"/>
                    <measurement group_id="O3" value="60.2" spread="5.6"/>
                    <measurement group_id="O4" value="56.3" spread="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Strawberry Dose-response Effect on Postprandial Oxidative Stress (Ox-LDL) in Insulin-resistant Men and Women in an Acute Postprandial Paradigm</title>
        <description>Postprandial plasma Ox-LDL concentration was measured by ELISA method. Normalizing responses to subjects own baseline (Time 0) was analyzed by SAS mixed model.</description>
        <time_frame>6 hours postprandial study over 4 periods(treatments)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Pbo&#xD;
Placebo: whole milk shake without strawberry powder served with the high fat/carbohydrate test meal</description>
          </group>
          <group group_id="O2">
            <title>10G STRB Powder</title>
            <description>Dose 1&#xD;
10G: whole milk shake with 10g strawberry powder served with the high fat/carbohydrate test meal</description>
          </group>
          <group group_id="O3">
            <title>20G STRB Powder</title>
            <description>Dose 2&#xD;
20G: whole milk shake with 20 strawberry powder served with the high fat/carbohydrate test meal</description>
          </group>
          <group group_id="O4">
            <title>40G STRB Powder</title>
            <description>Dose 3&#xD;
40G: whole milk shake with 40g strawberry powder served with the high fat/carbohydrate test meal</description>
          </group>
        </group_list>
        <measure>
          <title>Strawberry Dose-response Effect on Postprandial Oxidative Stress (Ox-LDL) in Insulin-resistant Men and Women in an Acute Postprandial Paradigm</title>
          <description>Postprandial plasma Ox-LDL concentration was measured by ELISA method. Normalizing responses to subjects own baseline (Time 0) was analyzed by SAS mixed model.</description>
          <units>U/L</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="21"/>
                <count group_id="O4" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="0.8"/>
                    <measurement group_id="O2" value="-0.3" spread="0.8"/>
                    <measurement group_id="O3" value="-3" spread="0.8"/>
                    <measurement group_id="O4" value="-0.17" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 years</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>Pbo&#xD;
Placebo: whole milk shake without strawberry powder served with the high fat/carbohydrate test meal</description>
        </group>
        <group group_id="E2">
          <title>10G STRB Powder</title>
          <description>Dose 1&#xD;
10G: whole milk shake with 10g strawberry powder served with the high fat/carbohydrate test meal</description>
        </group>
        <group group_id="E3">
          <title>20G STRB Powder</title>
          <description>Dose 2&#xD;
20G: whole milk shake with 20 strawberry powder served with the high fat/carbohydrate test meal</description>
        </group>
        <group group_id="E4">
          <title>40G STRB Powder</title>
          <description>Dose 3&#xD;
40G: whole milk shake with 40g strawberry powder served with the high fat/carbohydrate test meal</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The study had the following limitations: the study was single blinded and lack of data on other non-anthocyanin strawberry polyphenols and their metabolites may yield additional insight on the relationship between strawberry polyphenols &amp; bioactivity</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Britt Burton-Freeman</name_or_title>
      <organization>Illinois Institute of Techology</organization>
      <phone>708-341-0178</phone>
      <email>bburton@iit.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

